Bacterial endotoxin activates several mammalian biological cascades, including the coagulation, complementation and kallikrein systems. However, the mechanism(s) by which endotoxin generates enzymatically active components of these host cascades is unknown. Limulus polyphemus, the horseshoe crab, will be used to study the interactions between endotoxin and a host cascade system. Endotoxin activates a proteolytic blood coagulation that frequently accompanies sepsis (or endotoxemia) in man. The hypothesis to be tested is that a single, specific endotoxin- sensitive factor in Limulus is activated after interaction with bacterial endotoxin, with formation of an endotoxin-coagulation factor complex. This complex subsequently produces activation of the remaining factors of the blood coagulation cascade. To test the hypothesis, we will: 1. Identify which of the Limulus coagulation factors interacts directly with endotoxin and determine whether a stable complex is formed between endotoxin and the factor which interacts with endotoxin. If stable, the structure and stoichiometry of this complex will be determined. 2. Determine the structural changes (conformational, proteolytic of subunit changes) that are associated with activation of the endotoxin- sensitive coagulation factor as a result of its interactions with endotoxin. 3. Identify the chemical components of endotoxin that are required for interaction with the endotoxin-sensitive protein and those that are required for activation of this protein.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK043102-03
Application #
2142764
Study Section
Hematology Subcommittee 2 (HEM)
Project Start
1991-02-01
Project End
1995-01-31
Budget Start
1993-06-01
Budget End
1995-01-31
Support Year
3
Fiscal Year
1993
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Yoshida, M; Roth, R I; Grunfeld, C et al. (1996) Soluble (1-->3)-beta-D-glucan purified from Candida albicans: biologic effects and distribution in blood and organs in rabbits. J Lab Clin Med 128:103-14
Kaca, W; Roth, R I; Vandegriff, K D et al. (1995) Effects of bacterial endotoxin on human cross-linked and native hemoglobins. Biochemistry 34:11176-85
Yoshida, M; Roth, R I; Levin, J (1995) The effect of cell-free hemoglobin on intravascular clearance and cellular, plasma, and organ distribution of bacterial endotoxin in rabbits. J Lab Clin Med 126:151-60
Roth, R I; Kaca, W; Levin, J (1994) Hemoglobin: a newly recognized binding protein for bacterial endotoxins (LPS). Prog Clin Biol Res 388:161-72
Roth, R I (1994) Hemoglobin enhances the production of tissue factor by endothelial cells in response to bacterial endotoxin. Blood 83:2860-5
Roth, R I; Levin, J (1994) Measurement of endotoxin levels in hemoglobin preparations. Methods Enzymol 231:75-91
Roth, R I; Kaca, W (1994) Toxicity of hemoglobin solutions: hemoglobin is a lipopolysaccharide (LPS) binding protein which enhances LPS biological activity. Artif Cells Blood Substit Immobil Biotechnol 22:387-98
Kaca, W; Roth, R I; Levin, J (1994) Hemoglobin, a newly recognized lipopolysaccharide (LPS)-binding protein that enhances LPS biological activity. J Biol Chem 269:25078-84
Roth, R I; Levin, F C; Levin, J (1993) Distribution of bacterial endotoxin in human and rabbit blood and effects of stroma-free hemoglobin. Infect Immun 61:3209-15
Roth, R I; Levin, J; Chapman, K W et al. (1993) Production of modified crosslinked cell-free hemoglobin for human use: the role of quantitative determination of endotoxin contamination. Transfusion 33:919-24

Showing the most recent 10 out of 13 publications